Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Potential masking effect on dyspnoea perception by short- and long-acting beta2-agonists in asthma.

van Schayck CP, Bijl-Hofland ID, Cloosterman SG, Folgering HT, van der Elshout FJ, Van Weel C.

Eur Respir J. 2002 Feb;19(2):240-5.

3.

Inhaled corticosteroids, combined with long-acting beta(2)-agonists, improve the perception of bronchoconstriction in asthma.

Bijl-Hofland ID, Cloosterman SG, Folgering HT, van den Elshout FJ, van Weel C, van Schayck CP.

Am J Respir Crit Care Med. 2001 Sep 1;164(5):764-9.

PMID:
11549530
5.

Unaltered perception of dyspnoea during treatment with long-acting beta2-agonists.

van der Woude HJ, Aalbers R.

Eur Respir J. 2001 Aug;18(2):269-71.

6.

A placebo-controlled clinical trial of regular monotherapy with short-acting and long-acting beta(2)-agonists in allergic asthmatic patients.

Cloosterman SG, Bijl-Hofland ID, van Herwaarden CL, Akkermans RP, van Den Elshout FJ, Folgering HT, van Schayck CP.

Chest. 2001 May;119(5):1306-15.

PMID:
11348933
7.

Effects of long-acting and short-acting beta-agonists on methacholine dose-response curves in asthmatics.

Wong AG, O'Shaughnessy AD, Walker CM, Sears MR.

Eur Respir J. 1997 Feb;10(2):330-6.

8.
9.
10.

Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group.

FitzGerald JM, Chapman KR, Della Cioppa G, Stubbing D, Fairbarn MS, Till MD, Brambilla R.

J Allergy Clin Immunol. 1999 Mar;103(3 Pt 1):427-35.

PMID:
10069876
11.

Airway responsiveness to beta-adrenergic agonist (salbutamol) in asthma.

Boskabady MH, Saadatinejad M.

J Asthma. 2003 Dec;40(8):917-25.

PMID:
14736092
12.

[Asthma patients' perception of dyspnea during acute bronchoconstriction].

Martínez-Moragón E, Perpiñá M, Belloch A, de Diego A, Martínez-Francés ME.

Arch Bronconeumol. 2003 Feb;39(2):67-73. Spanish.

13.

Relation of the perception of airway obstruction to the severity of asthma.

Bijl-Hofland ID, Cloosterman SG, Folgering HT, Akkermans RP, van Schayck CP.

Thorax. 1999 Jan;54(1):15-19.

14.
15.

A comparison of breathlessness during spontaneous asthma and histamine-induced bronchoconstriction.

Boudreau D, Styhler A, Gray-Donald K, Martin JG.

Clin Invest Med. 1995 Feb;18(1):25-32.

PMID:
7768063
16.

Relief of dyspnoea by beta2-agonists after methacholine-induced bronchoconstriction.

van der Woude HJ, Postma DS, Politiek MJ, Winter TH, Aalbers R.

Respir Med. 2004 Sep;98(9):816-20.

PMID:
15338791
18.

Tolerance to the protective effects of salmeterol on methacholine-induced bronchoconstriction: influence of inhaled corticosteroids.

Boulet LP, Cartier A, Milot J, Côté J, Malo JL, Laviolette M.

Eur Respir J. 1998 May;11(5):1091-7.

19.
20.

Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment.

Yates DH, Sussman HS, Shaw MJ, Barnes PJ, Chung KF.

Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 1):1170-4.

PMID:
7551366
Items per page

Supplemental Content

Support Center